Biomarkers in fibromyalgia: a review

References

• Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600–610.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113–1122.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Sarzi-Puttini P. Old and new criteria for the classification and diagnosis of fibromyalgia: comparison and evaluation. Clin Exp Rheumatol. 2012;30(6 Suppl 74):S3–S9.
   Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–172.
   PubMed Web of Science ®Google Scholar
• Di Franco M, Iannuccelli C, Bazzichi L, et al. Misdiagnosis in fibromyalgia: a multicentre study. Clin Exp Rheumatol. 2011; 29(6 Suppl 69):S104–S108.
   PubMed Web of Science ®Google Scholar
• Bazzichi L, Rossi A, Giacomelli C, Bombardieri S. Exploring the abyss of fibromyalgia biomarkers. Clin Exp Rheumatol. 2010;28(6 Suppl 63): S125–S130.
   Web of Science ®Google Scholar
• Xiao Y, Russell IJ, Liu YG. A brain-derived neurotrophic factor polymorphism Val66Met identifies fibromyalgia syndrome subgroup with higher body mass index and C-reactive protein. Rheumatol Int. 2012;32(8):2479–2485.
   Web of Science ®Google Scholar
• Caccamo D, Cesareo E, Mariani S, et al. Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population. Oxid Med Cell Longev. 2013;2013:831969.
   PubMed Web of Science ®Google Scholar
• Smith SB, Maixner DW, Fillingim RB, et al. Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum. 2012;64(2):584–593.
   Google Scholar
• Potvin S, Larouche A, Normand E, et al. No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls. Eur J Pain. 2010;14(7):742–746.
   Web of Science ®Google Scholar
• Cohen H, Neumann L, Glazer Y, Ebstein RP, Buskila D. The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. Clin Exp Rheumatol. 2009;27(5 Suppl 56):S51–S56.
   PubMed Web of Science ®Google Scholar
• Ablin JN, Bar-Shira A, Yaron M, Orr-Urtreger A. Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha1-antitrypsin. Clin Exp Rheumatol. 2009;27(5 Suppl 56):S33–S38.
   Web of Science ®Google Scholar
• Tander B, Gunes S, Boke O, et al. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int. 2008;28(7):685–691.
   Web of Science ®Google Scholar
• Gürsoy S, Erdal E, Sezgin M, et al. Which genotype of MAO gene that the patients have are likely to be most susceptible to the symptoms of fibromyalgia? Rheumatol Int. 2008;28(4):307–311.
   Web of Science ®Google Scholar
• Wilson RB, Gluck OS, Tesser JR, Rice JC, Meyer A, Bridges AJ. Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity. J Rheumatol. 1999;26(2):402–407.
   Web of Science ®Google Scholar
• Wolfe F. “Silicone related symptoms” are common in patients with fibromyalgia: no evidence for a new disease. J Rheumatol. 1999;26(5): 1172–1175.
   PubMed Web of Science ®Google Scholar
• Bazzichi L, Giacomelli C, De Feo F, et al. Antipolymer antibody in Italian fibromyalgic patients. Arthritis Res Ther. 2007;9(5):R86.
   Web of Science ®Google Scholar
• Klein R, Berg PA. High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. Eur J Med Res. 1995;1(1):21–26.
   Google Scholar
• Nishikai M, Tomomatsu S, Hankins RW, et al. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Rheumatology. 2001;40(7):806–810.
   PubMed Web of Science ®Google Scholar
• Bazzichi L, Rossi A, Giuliano T, et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol. 2007;26(12):2115–2120.
   Web of Science ®Google Scholar
• Bazzichi L, Rossi A, Zirafa C, et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol. 2012;32(2):335–341.
   Web of Science ®Google Scholar
• Suk JH, Lee JH, Kim JM. Association between thyroid autoimmunity and fibromyalgia. Exp Clin Endocrinol Diabetes. 2012;120(7):401–404.
   Web of Science ®Google Scholar
• Ribeiro LS, Proietti FA. Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J Rheumatol. 2004;31(10): 2036–2040.
   Web of Science ®Google Scholar
• Cordero MD, Cotán D, del-Pozo-Martín Y, et al. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition. 2012;28(11–12):1200–1203.
   PubMed Web of Science ®Google Scholar
• Cordero MD, Cano-García FJ, Alcocer-Gómez E, De Miguel M, Sánchez-Alcázar JA. Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q10 effect on clinical improvement. PLoS One. 2012;7(4):e35677.
   PubMed Web of Science ®Google Scholar
• Miyamae T, Seki M, Naga T, et al. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep. 2013;18(1):12–19.
   PubMed Web of Science ®Google Scholar
• Meeus M, Nijs J, Hermans L, Goubert D, Calders P. The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets? Expert Opin Ther Targets. 2013;17(9):1081–1089.
   PubMed Web of Science ®Google Scholar
• Castro-Marrero J, Cordero MD, Sáez-Francas N, et al. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal. 2013;19(15): 1855–1860.
   PubMed Web of Science ®Google Scholar
• Neyal M, Yimenicioglu F, Aydeniz A, et al. Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg. 2013;115(6):736–740.
   PubMed Web of Science ®Google Scholar
• Bote ME, García JJ, Hinchado MD, Ortega E. Inflammatory/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation. 2012;19(6):343–351.
   PubMed Web of Science ®Google Scholar
• Giacomelli C, Bazzichi L, Giusti L, et al. [MALDI-TOF and SELDI-TOF analysis: “tandem” techniques to identify potential biomarker in fibromyalgia]. Reumatismo. 2011;63(3):165–170. Italian.
   Google Scholar
• Altindag O, Gur A, Calgan N, Soran N, Celik H, Selek S. Paraoxonase and arylesterase activities in fibromyalgia. Redox Rep. 2007;12(3): 134–138.
   PubMed Web of Science ®Google Scholar
• Uçeyler N, Häuser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord. 2011;12:245.
   PubMed Web of Science ®Google Scholar
• Bote ME, Garcia JJ, Hinchado MD, Ortega E. Fibromyalgia: anti-inflammatory and stress responses after acute moderate exercise. PLoS One. 2013;8(9):e74524.
   PubMed Web of Science ®Google Scholar
• Pernambuco AP, Schetino LP, Alvim CC, et al. Increased levels of IL-17A in patients with fibromyalgia. Clin Exp Rheumatol. 2013; 31(6 Suppl 79):S60–S63.
   PubMed Web of Science ®Google Scholar
• Ross RL, Jones KD, Bennett RM, Ward RL, Druker BJ, Wood LJ. Preliminary evidence of increased pain and elevated cytokines in fibromyalgia patients with defective growth hormone response to exercise. Open Immunol J. 2010;3:9–18.
   PubMedGoogle Scholar
• Iannuccelli C, Di Franco M, Alessandri C, et al. Pathophysiology of fibromyalgia: a comparison with the tension-type headache, a localized pain syndrome. Ann N Y Acad Sci. 2010;1193:78–83.
   Web of Science ®Google Scholar
• Togo F, Natelson BH, Adler GK, et al. Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med (Maywood). 2009;234(2):232–240.
   Web of Science ®Google Scholar
• Bazzichi L, Rossi A, Massimetti G, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol. 2007;25(2):225–230.
   Web of Science ®Google Scholar
• Werle E, Jäkel HP, Müller A, Fischer H, Fiehn W, Eich W. Serum hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome. Clin Lab. 2005;51(1–2):11–19.
   Web of Science ®Google Scholar
• Wigley RD, Page B, Chambers EM. Hyaluronic acid serum levels in fibromyalgia, nonspecific arm disorder, and controls. J Rheumatol. 2001;28(11):2563.
   Web of Science ®Google Scholar
• Maes M, Verkerk R, Delmeire L, Van Gastel A, van Hunsel F, Scharpé S. Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia. Psychiatry Res. 2000;97(1):11–20.
   PubMed Web of Science ®Google Scholar
• Bazzichi L, Palego L, Giannaccini G, et al. Altered amino acid homeostasis in subjects affected by fibromyalgia. Clin Biochem. 2009;42(10–11):1064–1070.
   Web of Science ®Google Scholar
• Jaschko G, Hepp U, Berkhoff M, et al. Serum serotonin levels are not useful in diagnosing fibromyalgia. Ann Rheum Dis. 2007;66(9): 1267–1268.
   Web of Science ®Google Scholar
• Offenbaecher M, Bondy B, de Jonge S, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42(11):2482–2488.
   PubMedGoogle Scholar
• Bazzichi L, Giannaccini G, Betti L, et al. Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther. 2006;8(4):R99.
   Web of Science ®Google Scholar
• Dorshkind K, Horseman ND. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev. 2000;21(3): 292–312.
   Web of Science ®Google Scholar
• Ablin JN, Aronov N, Shimon I, et al. Evaluation of leptin levels among fibromyalgia patients before and after three months of treatment, in comparison with healthy controls. Pain Res Manag. 2012;17(2): 89–92.
   Web of Science ®Google Scholar
• Giusti L, Baldini C, Ciregia F, et al. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? Proteomics Clin Appl. 2010;4(3):315–324.
   PubMed Web of Science ®Google Scholar
• Baldini C, Giusti L, Ciregia F, et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren’s syndrome from secondary Sjögren’s syndrome and other sicca syndromes. Arthritis Res Ther. 2011;13(6):R194.
   PubMed Web of Science ®Google Scholar
• Baldini C, Giusti L, Bazzichi L, et al. Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement? J Rheumatol. 2008;35(9):1820–1824.
   Web of Science ®Google Scholar
• Bazzichi L, Ciregia F, Giusti L, et al. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin Appl. 2009;3(11):1296–1304.
   PubMed Web of Science ®Google Scholar
• Samland AK, Sprenger GA. Transaldolase: from biochemistry to human disease. Int J Biochem Cell Biol. 2009;41(7):1482–1494.
   Web of Science ®Google Scholar